• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Lumicell

8 breast cancer tech stories you need to know

October 9, 2024 By Danielle Kirsh

October is Breast Cancer Awareness Month, a critical time to spotlight the latest innovations in medical devices designed to improve breast cancer diagnosis, treatment and patient outcomes. Breast cancer is a group of abnormal cells growing uncontrolably, starting in the breast tissue. Nearly all cases of breast cancer affect women, but men can get the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Hospital Care, Imaging, Mammography, Oncology, Radiosurgery/Radiation therapy, Research & Development, Ultrasound, Women's Health Tagged With: Cairn Surgical, Innoblative, Lumicell, Mayo Clinic, Melodi Health, Merit Medical, Molli Surgical, Siemens Healthineers, SimBioSys

The top 10 women’s health stories of the year so far

October 4, 2024 By Danielle Kirsh

It has been a blockbuster year for women’s health as the federal government and medtech place particular focus on the wellbeing of women. At the start of the year, President Joe Biden announced the federal government would focus its health initiatives on improving women’s health outcomes. Since then, his administration has announced two other federal […]

Filed Under: Cardiovascular, Catheters, Diagnostics, Featured, Genomics/Molecular Diagnostics, Gynecological, Hospital Care, Imaging, Implants, Mammography, News Well, Oncology, Radiosurgery/Radiation therapy, Regulatory/Compliance, Robotic-Assisted, Structural Heart, Surgical Robotics, Ultrasound, Women's Health Tagged With: Cairn Surgical, Edwards Lifesciences, GE Healthcare, Hologic, Lumicell, Melodi Health, Moon Surgical, Virtual Incision, White House

FDA approves Lumicell’s breast cancer visualization system

April 18, 2024 By Danielle Kirsh

Lumicell today announced it received FDA approval for its LumiSystem direct visualization system for breast cancer removal. According to the company, the LumiSystem allows surgeons to scan the breast cavity post-lumpectomy in real time to detect and resect residual cancer that could have been missed with 84% diagnostic accuracy. The LumiSystem with the company’s LumiSight […]

Filed Under: Oncology, Women's Health Tagged With: Lumicell

Lumicell earns positive FDA panel decision on surgical imaging tool, approval decision expected soon

March 8, 2024 By Sean Whooley

Lumicell announced that an FDA advisory committee voted in support of the benefit-risk profile of its LumiSight offering. LumiSight, an optical imaging agent, works in combination with the Lumicell direct visualization system (DVS) in breast cancer imaging. The combination product — a fluorescence-guided surgical imaging tool — detects residual cancer in real-time during a lumpectomy. […]

Filed Under: Food & Drug Administration (FDA), Imaging, Mammography, Oncology, Regulatory/Compliance Tagged With: Lumicell

Lumicell closes enrollment of feasibility trial

August 19, 2019 By Sean Whooley

Lumicell said it completed enrollment in a Phase C feasibility clinical trial for its intraoperative breast cancer imaging system. The Newton, Mass.-based company expects results later this year and plans to start a pivotal trial by the end of 2019 before it applies for FDA approval. Lumicell’s imaging system is designed to enable surgeons to […]

Filed Under: Clinical Trials, Imaging, Oncology, Surgical Tagged With: Lumicell

Motus GI taps Moran as CEO | Personnel Moves – September 25, 2018

September 25, 2018 By Fink Densford

Motus GI said today that it named Timothy Moran as its new chief executive officer, effective October 1, replacing former CEO Mark Pomeranz who will assume the role of president and COO. Moran has previously served ConvaTec‘s (LON:CTEC) Americas president and helped lead the company through its initial public offering in 2016. Prior to ConvaTec, Moran spent […]

Filed Under: Business/Financial News Tagged With: Allurion Technologies, Baxter, biomedgps, Bristol-Myers Squibb Co., ConvaTec, Covidien, Integra LifeSciences, Lumicell, Mallinckrodt, MedX Health, MOTUS GI, Myomo Inc, National Institutes of Health (NIH), Natus Medical Inc., northstarmedicaltechnologies, Personnel Moves, Pursuit Vascular, ReWalk Robotics

This new technology could help surgeons clear out leftover cancer cells

March 27, 2018 By Sarah Faulkner

In some instances, as many as 30% of patients need repeat surgeries get rid of cancerous cells initially left behind. The team from Lumicell wants to change that — and improve outcomes for cancer patients. [Image by MDO art director Matthew Claney] After his wife died of breast cancer in 2003, David Lee stepped away from […]

Filed Under: Diagnostics, Drug-Device Combinations, Imaging, Oncology, Pharmaceutical, Surgical Tagged With: Lumicell

Lumicell aims $29m Series C at pivotal breast cancer trial and expansion into other cancers

December 7, 2017 By Sarah Faulkner

With $28.7 million from a recently-closed Series C round, Lumicell reported today that it plans to launch a pivotal trial of its image-guided cancer surgery tech in breast cancer. The Wellesley, Mass.-based company added that it hopes to expand its clinical program into other solid tumor cancers, including lung, ovarian and brain cancer. Get the full story at our sister site, Drug Delivery Business […]

Filed Under: Clinical Trials, Drug-Device Combinations, Oncology, Pharmaceutical, Surgical Tagged With: Lumicell

Lumicell raises $21m for image-guided cancer surgery tech

October 24, 2017 By Sarah Faulkner

Lumicell has raised $20.7 million over the past three months, according to a regulatory document filed with SEC last week. More than 20 investors have contributed to the $26.5 million equity offering, the Wellesley, Mass.-based company reported, including one investor outside of the U.S. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Drug-Device Combinations, Funding Roundup, Imaging, Oncology, Surgical Tagged With: Lumicell

Lumicell launches breast cancer, prostate cancer trials with Lum image-guided system

September 6, 2017 By Sarah Faulkner

Lumicell said today that it is launching clinical studies in breast cancer and prostate cancer with its Lum image-guided cancer surgery system. The breast cancer trial is a pivotal study following an initial training period with surgeons, the Wellesley, Mass.-based company reported, and the prostate cancer study is a first for Lumicell and its technology, Most […]

Filed Under: Clinical Trials, Drug-Device Combinations, Oncology, Surgical Tagged With: Lumicell

Lumicell taps ex-Accuray COO Londy as CEO | Personnel Moves July 18, 2017

July 19, 2017 By Fink Densford

Lumicell said last week it tapped former Accuray (NSDQ:ARAY) chief operating officer Kelly Londy as its new chief exec, with founder W. Lee moving to take the role of prez & chief scientific officer. Prior to holding the COO position at Accuray, Londy has held leadership positions at GE Healthcare (NYSE:GE) and Royal Philips (NYSE:PHG), Lumicell said. “We are […]

Filed Under: Business/Financial News Tagged With: Accuray Inc., Aptus EndoSystems Inc., Asante Solutions, AtriCure Inc., AxoGen, C.R. Bard, Cerner Corp., Cutera Inc., Eos Imaging, GE Healthcare, Lumicell, Mannkind Corp., Personnel Moves, Philips, Ventus Medical Inc., VertiFlex Inc., Zecotec

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy